STORY CONTINUES BELOW THESE SALTWIRE VIDEOS - CVS Health Corp said on Wednesday it has launched Cordavis, a unit that will work directly with manufacturers to commercialize and co-produce biosimilars for the U.S. market.
The company will also launch biosimilar Hyrimoz with Novartis' Sandoz from next year at a list price that is more than 80% lower to AbbVie's blockbuster arthritis drug Humira.
Portugal Últimas Notícias, Portugal Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Fonte: SaltWire Network - 🏆 45. / 63 Consulte Mais informação »